Abstract:

The data about the prevalence of hypertension of approximately one hundred patients was collected by interviewing them in Narowal, Pakistan. The data had been analyzed to determine the relative occurrence and incidence of hypertension by different age groups. The analysis showed the prevalence of hypertension was more in females (64%, n=64/100) as compared to males (34%, n=34/100). Hypertension was more prevalent in age group 38-47 years (32%) and less prevalent in age group 68-77 years (6%). In our sample population the prevalence of hypertension by age group 18-27 years was 13%, age group 28-37 years was 16%, age group 38-47 years was 32%, age group 48-57 years was 18%, age group 58-67 years was 15% and by age group 68-77 years was 6%. Known as “the silent killer”, the disease may prevail without symptoms for prolonged periods so there is requirement of investigations to know the exact rate and risk factor of this overwhelming disease.

Keywords:

Hypertension, incidence, age groups, symptoms.

Citation:

Iqbal, M.N., Ashraf, A., Iqbal, I., Iqbal, A., Alam, S., Yunus, F.N., 2018. Incidence of Hypertension among Various Age Groups in Narowal, Pakistan. Int. J. Nanotechnol. Allied Sci., 2(2): 12-15.

REFERENCES

Berenson, G.S., Srinivasan, S.R., Hunter, S.M., Nicklas, T.A., Freedman, D.S., Shear, C.L., Webber, L.S., 2003. Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart Study. Am. J. Med. Sci., 298: 141-151.

Bloch, M.J., 2016. Worldwide prevalence of hypertension exceeds 1.3 billion. J. Am. Soc. Hypertens., 10(10): 753–754.

Coresh, J., Wei, G.L., McQuillan, S.R., Brancati, F.L., Levey, A.S., Jones, C., Klag, M.J., 2001. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988–1994). Arch. Intern. Med., 161: 1207-1216.

Guyton, T., Hall, H.S., 2005. Hypertension can be classified either essential (primary) or secondary. Essential hypertension indicates that no specific medical cause can be found to explain a patient’s condition. 79: 161-170.

Iqbal, M.N., Ashraf, A., Shahzad, M.I., Alam, S., Xioa, S., Toor, S., 2016. The Causes of Hypertension in Human Population visiting Sughra Shafih Medical Complex. PSM Biol. Res., 01(2): 78-82.

Kannel, W.B., Vasan, R.S., Levy, D., 2003. Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values? Hypertens., 42: 453-456.

Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K.,

Adair-Rohani, H., et al., 2012. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a  systematic analysis  for  the Global  Burden of Disease Study 2010. The Lancet., 380(9859): 2224-60.

Nissinen, A., Hall, H.S., Jones, C., 1988. Hypertension in developing countries. Arch. Intern. Med., 41: 141-154.

Norwood, V.F., 2002. Hypertension. Pediatr. Rev., 23: 197-208.

Ong, K.L., Cheung, B.M., Man, Y.B., Lau, C.P., Lam, K.S., 2007. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 49(1):69-75.

Raza, M., Mahboob, A., Agha, A., Sikandar, Q.M., 2000. Prevalence of hypertension in Punjab. Pak. J. Med. Res., 9(3): 2-5.

Sontia, B., Mooney, J., Gaudet, L., Touyz, R.M., 2008. “Pseudohyper-aldosteronism, liquorice, and hypertension”. J. Clin. Hypertens., 10(2): 153-157.

Thomas, S.J., Booth John, N., Dai, C., Li, X., Allen, N., Calhoun, D., et al. 2018. Cumulative Incidence of Hypertension by 55 Years of Age in Blacks and Whites: The CARDIA Study. J. Am. Heart Assoc., 7(14): e007988.

Welton, P.K., 1994.Epidemiology of hypertension. Lancet., 344: 191-196.

World Health Organization, 2013. A global brief on hypertension:  silent  killer,  global  public  health  crisis: World Health Day 2013.